Anxiety and cardiac disease

Primary Psychiatry

Volumn 12, Issue 3, 2005, Pages 47-50

  McCann, Una D ^a,b,c   Fauerbach, James A ^a   Thombs, Brett D ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

^c PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN UPTAKE INHIBITOR;

ACUTE STRESS DISORDER; ANXIETY; ANXIETY DISORDER; BEHAVIOR THERAPY; COGNITIVE THERAPY; DISEASE ASSOCIATION; EMOTION; HEART DISEASE; HUMAN; HYPOTHESIS; MORBIDITY; MORTALITY; PANIC; POSTTRAUMATIC STRESS DISORDER; PRACTICE GUIDELINE; REVIEW; RISK FACTOR;

EID: 15744366375     PISSN: 10826319     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Kubzansky LD, Kawachi I, Spiro A 3rd, Weiss ST, Vokonas PS, Sparrow D. Is worrying bad for your heart? A prospective study of worry and coronary heart disease in the Normative Aging Study. Circulation. 1997;95(4):818-824.
2. Kubzansky LD, Kawachi I. Going to the heart of the matter: do negative emotions cause coronary heart disease? J Psychosom Res. 2000;48(4-5):323-337.
3. Eng PM, Fitzmaurice G, Kubzansky LD, Rimm EB, Kawachi I. Anger expression and risk of stroke and coronary heart disease among male health professionals. Psychosom Med. 2003;65(1):100-100.
4. Rozanski A, Blumenthal JA, Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation. 1999;99(16):2192-2217.
5. Kawachi I, Sparrow D, Vokonas PS, Weiss ST. Symptoms of anxiety and risk of coronary heart disease. The Normative Aging Study. Circulation. 1994;90(5):2225-2229.
6. Kawachi I, Colditz GA, Ascherio A, et al. Prospective study of phobic anxiety and risk of coronary heart disease in men. Circulation. 1994;89(5):1992-1997.
7. Carney RM, Freedland KE, Jaffe AS, et al. Depression as a risk factor for post-MI mortality. J Am Coll Cardiol. 2004;44(2):472.
8. van Melle JP, de Jonge P, Spijkerman TA, et al. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosom Med. 2004;66(6):814-822.
9. Strik JJ, Denollet J, Lousberg R, Honig A. Comparing symptoms of depression and anxiety as predictors of cardiac events and increased health care consumption after myocardial infarction. J Am Coll Cardiol. 2003;42(10):1801-1807.
10. Grace SL, Abbey SE, Irvine J, Shnek ZM, Stewart DE. Prospective examination of anxiety persistence and its relationship to cardiac symptoms and recurrent cardiac events. Psychother Psychosom. 2004;73(6):344-352.
11. Akhtar MS, Malik SB, Ahmed MM. Symptoms of depression and anxiety in post-myocardial infarction patients. J Coll Physicians Surg Pak. 2004;14(10):615-618.
12. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51(1):8-19.
13. Harter MC, Conway KP, Merikangas KR. Associations between anxiety disorders and physical illness. Eur Arch Psychiatry Clin Neurosci. 2003;253(6):313-320.
14. Lavoie KL, Fleet RP, Laurin C, Arsenault A, Miller SB, Bacon SL. Heart rate variability in coronary artery disease patients with and without panic disorder. Psychiatry Res. 2004;128(3):289-299.
15. Albert CM, Chae CU, Rexrode KM, Manson JE, Kawachi I. Phobic anxiety and risk of coronary heart disease and sudden cardiac death among women. Circulation. 2005;111(4):480-487.
16. Lavie CJ, Milani RV. Prevalence of anxiety in coronary patients with improvement following cardiac rehabilitation and exercise training. Am J Cardiol. 2004;93(3):336-339.
17. Haines AP, Imeson JD, Meade TW. Phobic anxiety and ischaemic heart disease. Br Med J (Clin Res Ed). 1987;295(6593):297-299.
18. Frasure-Smith N, Lesperance F, Gravel G, Masson A, Juneau M, Bourassa MG. Long-term survival differences among low-anxious, high-anxious and repressive copers enrolled in the Montreal heart attack readjustment trial. Psychosom Med. 2002;64(4):571-579.
19. Carinci F, Nicolucci A, Ciampi A, et al, for the Gruppo Italiano per lo Studio della Sopravvivenza nell; Infarto Miocardico. Role of interactions between psychological and clinical factors in determining 6-month mortality among patients with acute myocardial infarction. Application of recursive partitioning techniques to the GISSI-2 database. Eur Heart J. 1997;18(5):835-845.
20. Hermann C, Brand-Driehorst S, Buss U, Ruger U. Effects of anxiety and depression on 5-year mortality in 5,057 patients referred for exercise testing. J Psychosom Res. 2000;48(4-5):455-462.
21. Mayou R, Williamson B, Foster A. Attitudes and advice after myocardial infarction. Br Med J. 1976;1(6025):1577-1579.
22. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
23. McCann UD, Roca R. Anxiety and anxiety disorders. In: Barker LR, Burton JR, Zieve PH, eds. Principles of Ambulatory Medicine. 6th ed. Philadelphia, PA: Lippincott, Williams & Wilkins; 2003:263-279.
24. Davidson JR, Stein DJ, Shalev AY, Yehuda R. Posttraumatic stress disorder: acquisition, recognition, course, and treatment. J Neuropsychiatry Clin Neurosci. 2004;16(2):135-147.
25. Ursano RJ, Bell C, Eth S, et al, for the Work Group on ASD and PTSD and the Steering Committee on Practice Guidelines. Practice guideline for the treatment of patients with acute stress disorder and posttraumatic stress disorder. Am J Psychiatry. 2004;161(suppl 11):3-31.
26. Marks IM, Swinson RP, Basoglu M, et al. Alprazolam and exposure alone and combined in panic disorder with agoraphobia. A controlled study in London and Toronto. Br J Psychiatry. 1993;162:776-787.
27. van Balkom AJ, de Beurs E, Koele P, Lange A, van Dyck R. Long-term benzodiazepine use is associated with smaller treatment gain in panic disorder with agoraphobia. J Nerv Ment Dis. 1996;184(2):133-135.
28. Gamper G, Willeit M, Sterz F, et al. Life after death: posttraumatic stress disorder in survivors of cardiac arrest - prevalence, associated factors, and the influence of sedation and analgesia. Crit Care Med. 2004;32(2):378-383.
29. Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry. 1995;52(12):1048-1060.
30. Connolly D, McClowry S, Hayman L, Mahony L, Artman M. Posttraumatic stress disorder in children after cardiac surgery. J Pediatr. 2004;144(4):480-484.
31. Hamner M, Hunt N, Gee J, Garrell R, Monroe R. PTSD and automatic implantable cardioverter defibrillators. Psychosomatics. 1999;40(1):82-85.
32. Neel M. Posttraumatic stress symptomatology in patients with automatic implantable cardioverter defibrillators: nature and intervention. Int J Emerg Ment Health. 2000;2(4):259-263.
33. Godemann F, Butter C, Lampe F, Linden M, Schlegl M, Schultheiss HP, Behrens S. Panic disorders and agoraphobia: side effects of treatment with an implantable cardioverter/defibrillator. Clin Cardiol. 2004;27(6):321-326.
34. Bovasso G, Eaton W. Types of panic attacks and their association with psychiatric disorder and physical illness. Compr Psychiatry. 1999;40(6):469-477.
35. Lombardi F, Makikallio TH, Myerburg RJ, Huikuri HV. Sudden cardiac death: role of heart rate variability to identify patients at risk. Cardiovasc Res. 2001;50(2):210-217.
36. Routledge HC, Chowdhary S, Townend JN. Heart rate variability - a therapeutic target? J Clin Pharm Ther. 2002;27(2):85-92.
37. Gorman JM, Sloan RP. Heart rate variability in depressive and anxiety disorders. Am Heart J. 2000;140(suppl 4):77-83.